BioInvent International AB CEO Presentation - Pre Recorded Transcript
Welcome to my update on BioInvent. I'm Martin Welschof, and I'm the CEO of the company.
On slide 2, you see our forward-looking statement, and I want to start with a quick company snapshot. BioInvent is a leading immuno-oncology antibody company, focusing on immunotherapy by overcoming tumor resistance. We are highly integrated and cover the value chain from discovery, manufacturing until and including clinical development.
With our unique core technology, we have generated a portfolio of programs with currently four programs in the clinic. This platform has been validated by a number of collaborations, most recently by Pfizer. We are listed on the Stockholm Stock Exchange and have a diversified shareholder base, including high-quality institutions such as Redmile, Van Herk Investments, Omega, HBM, MÃ
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
